Olutasidenib

Olutasidenib


Olutasidenib is a brain-penetrant, selective inhibitor of mutant IDH1, studied for treating AML and MDS by targeting aberrant metabolic activity in cancer cells.

Molecular structure of the compound BP-44036
    • Unit
    • Price
    • Qty
    • 10 MG
    • $150.00
    • 25 MG
    • $240.00
    • 50 MG
    • $420.00
    • 100 MG
    • $680.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire